(Q40396114)

20 September 2017

title

Burden of illness and satisfaction with care among patients with headache seen in a primary care setting (English)

1 reference

20 September 2017

0 references

Stephen D. Silberstein

4

object named as

Stephen D Silberstein

1 reference

20 September 2017

Linda H Harpole

1

1 reference

20 September 2017

Gregory P Samsa

2

1 reference

20 September 2017

David B Matchar

3

1 reference

20 September 2017

Andrew Blumenfeld

5

1 reference

20 September 2017

Annette E Jurgelski

6

1 reference

20 September 2017

publication date

1 September 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

45

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

1048-1055

1 reference

The prevalence and characteristics of migraine in a population-based cohort: the GEM study

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Variation in migraine prevalence by race.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Migraine in the United States: epidemiology and patterns of health care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Epidemiology of tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Impact of migraine in the United States: data from the National Health Interview Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Economic and social impact of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Prediction of physician visits and prescription medicine use for back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Migraine preventive medication reduces resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05186.X

10.1111/J.1526-4610.2005.05186.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference